Mergers and Acquisitions in India¡¯s Pharmaceutical Sector
A merger and acquisition (M&A) refers an arrangement whereby the assets, liabilities and business of two companies become vested in or under the control of one company. M&A is a tool for expanding business or get around different laws or regulations such as tax laws or monopoly regulations. This paper aims to examine the impact of M&A on the financial performance of the companies involved in pharmaceutical industry. For this purpose, a case study of GlaxoSmithKline has been selected. The pre and post-merger performances, in terms of variables like sales, net earnings, debt equity ratio and return on equity ratio of the company, have been analyzed by applying independent sample t test as a main statistical tool.
Volume (Year): 6 (2014)
Issue (Month): 1 (March)
|Contact details of provider:|| Postal: 1568 Merivale Rd. Suite # 618, Ottawa, Ontario, Canada K2G 5Y7|
When requesting a correction, please mention this item's handle: RePEc:oul:tncr09:v:6:y:2014:i:1:p:86-100. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Denny Liao)or (Jen Ma)
If references are entirely missing, you can add them using this form.